6Joseph A. Khawly,Peter Saloupis,Diane L. Hatchell,Robert Machemer. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy[J] 1991,Graefe’s Archive for Clinical and Experimental Ophthalmology(5):464～467 被引量：1
7Peter Wiedemann,Claudia Leinung,Ralf-Dieter Hilgers,Klaus Heimann. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy[J] 1991,Graefe’s Archive for Clinical and Experimental Ophthalmology(2):150～152 被引量：1
8George W. Blankenship. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases[J] 1989,Graefe’s Archive for Clinical and Experimental Ophthalmology(6):565～568 被引量：1
9M. Santana,P. Wiedemann,M. Kirmani,D. S. Minckler,R. Patterson,N. Sorgente,S. J. Ryan. Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit[J] 1984,Graefe’s Archive for Clinical and Experimental Ophthalmology(5):210～213 被引量：1
10S. Binder,B. Riss,Ch. Skorpik,W. Kulnig. Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil[J] 1983,Graefe’s Archive for Clinical and Experimental Ophthalmology(3):126～129 被引量：1
1Chen, W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2) :115 - 132. 被引量：1
2Silverstein RA,Gonzez de Valdivia E,Visa N. The incorporation of 5-fluowurtil into RNA affects the ribonucleolytic activity ff the exo- some sub,nit Rrp6[ J]. Mol Cancer Res,2011,9(3) :332 -340. 被引量：1
3Okamura M, Shimada J, Sakagami H. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines [ J ]. Anticancer Res, 2008,28 ( 1 A) :253 - 259. 被引量：1
4Chibber S,Farhan M,Hassan I,et al. White light-mediated Cu(]I)- 5FU interaction augments the chemotherapeutic potential of 5-FU :an in vitro study [ J ]. Tumour Biol, 2011,32 ( 5 ) : 881 - 892. 被引量：1
5Zhou, W, Yuan J. Necroptosis in health and diseases [ J ]. Semin Cell Dev Biol,2014,35:14 -23. 被引量：1
6Fulda S. Therapeutic exploitation of necroptosis for cancer therapy [ J]. Semin Cell Dev Bio1,2014 ,35 :51 -56. 被引量：1
7Lee, J J, Beumer JH, Chu E. Therapeutic drug monitoring of 5-flu- orouracil[ J]. Cancer Chemother Pharmaco1,2016 ,20 : 1 - 18. 被引量：1
8Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. Molecular mechanisms of necroptosis : an ordered cellular explosion [ J ]. Nat Rev Mol Cell Biol,2010,11 (10) :700 -714. 被引量：1
9Han W, Li L, Qiu S,et al. Shikonin circumvents cancer drug resist- ance by induction of a necroptotic death [ J ]. Mol Cancer Ther, 2007,6(5) :1641 - 1649. 被引量：1
10Xuan, Y, Hu X. Naturally-occurring shikonin analogues - a class of neeroptotic inducers that circumvent cancer drug resistance [ J ]. Cancer Lett,2009,274 (2) :233 - 242. 被引量：1
